Preclinical evaluation of a replication-deficient intranasal ΔNS1 H5N1 influenza vaccine animal models confirmed the safety and immunogenicity of the vaccine.
Intranasal immunization protected
IMMUNOPATHOGENESIS AND PERSPECTIVES FOR IMMUNOTHERAPY OF CORONAVIRUS INFECTION clinical manifestations and death. COVID-19 immunopathogenesis is linked with dysregulated
immune response